Can I Take Calcium with Tadalafil (Generic)?

Direct answer: No pharmacokinetic interaction between calcium and tadalafil is established in the FDA label or in the general pharmacology of either substance. Tadalafil is generic oral tadalafil (2.5 mg to 20 mg tablets; brand name Cialis for erectile dysfunction and benign prostatic hyperplasia, brand name Adcirca at a different dose for pulmonary arterial hypertension), a phosphodiesterase type-5 (PDE5) inhibitor cleared almost entirely by hepatic CYP3A4. Calcium is absorbed intestinally through vitamin D-dependent channels and does not touch CYP3A4. The genuinely useful question for most readers is not "does calcium interact with tadalafil" but "does my calcium supplement interact with something else I take alongside tadalafil", because that is where the real, well-documented interactions sit.

What tadalafil is and how it works

Tadalafil is a PDE5 inhibitor. It blocks the enzyme phosphodiesterase type 5, which raises cyclic GMP in smooth muscle and produces vasodilation in penile and prostatic tissue. Generic tadalafil is FDA-approved for erectile dysfunction (10 mg or 20 mg on demand, or 2.5 to 5 mg once daily) and for benign prostatic hyperplasia (5 mg once daily). A separate, higher-dose formulation marketed as Adcirca is approved for pulmonary arterial hypertension; that indication and dosing are not the subject of this page.

Tadalafil is absorbed orally, reaches peak plasma concentration around 2 hours after a dose, and has a long elimination half-life of roughly 17.5 hours according to the FDA prescribing information, which is why on-demand dosing has an extended window of effect (FDA tadalafil label). It is metabolized almost entirely by hepatic CYP3A4 to inactive metabolites.

Does calcium directly interact with tadalafil?

Calcium is a divalent cation absorbed in the small intestine through vitamin D-regulated transport. Tadalafil clearance depends on hepatic CYP3A4. These are unrelated systems, and calcium does not inhibit or induce CYP3A4 at physiologic concentrations. The FDA tadalafil label's drug interaction section addresses potent CYP3A4 inhibitors (such as ketoconazole and ritonavir), nitrates, alpha-blockers, other antihypertensives, and alcohol. Calcium supplements do not appear in that section (FDA label).

Tadalafil is also highly protein-bound (approximately 94%, mainly to albumin and alpha-1-acid glycoprotein). There is no known mechanism by which calcium would displace tadalafil from these binding sites.

What this does not tell you: the absence of a listed interaction is not the same as a dedicated interaction trial having been conducted and published. No controlled pharmacokinetic study of tadalafil plus supplemental calcium is cited in the FDA label or in the general pharmacology literature reviewed for this page. The clinical inference (no interaction expected) rests on mechanism, not on a specific head-to-head trial, and that distinction matters if a reader is looking for trial-level proof rather than mechanistic reasoning.

Cardiovascular considerations: the part that actually needs judgment

Tadalafil produces mild systemic vasodilation. The FDA label's pharmacodynamic data describe a modest reduction in supine blood pressure at the 20 mg on-demand dose compared with placebo; the effect is small in people with normal cardiovascular status and more relevant in people already on antihypertensive therapy, which is one reason prescribers often start lower and titrate (FDA label).

Calcium's cardiovascular signal is separately debated in the literature. Some randomized trial data and pooled analyses have raised a question about whether calcium supplementation taken without co-administered vitamin D is associated with an increase in cardiovascular events, particularly myocardial infarction, while other large trials (including calcium-plus-vitamin-D designs) have not shown a clear signal. A major national preventive-services guideline body has reviewed this evidence and concluded that current data are insufficient to make a general recommendation for or against calcium and vitamin D supplementation for fracture prevention in community-dwelling adults, which reflects genuine uncertainty rather than a settled answer.

Because the specific trials behind the "27 to 31 percent increased risk" figure that circulates in secondary sources could not be verified against a primary source for this draft, that number is not repeated here as an established fact. Anyone relying on a specific relative-risk figure should ask their prescriber or pharmacist to pull the primary meta-analysis rather than accept the number secondhand.

Practical implication: men taking tadalafil for ED or BPH frequently also carry cardiovascular risk factors (hypertension, metabolic syndrome, type 2 diabetes). In that population, adding supplemental calcium beyond what dietary intake already provides is a reasonable thing to discuss with a clinician, not because tadalafil and calcium interact, but because the calcium-cardiovascular question is unsettled and the patient population already carries baseline risk.

Where calcium's real interactions live: other drugs in your regimen

The clinically significant calcium interactions are not with tadalafil. They are with other common co-prescriptions.

Levothyroxine

Calcium carbonate binds levothyroxine in the gut and reduces its absorption; this is a well-established, clinically recognized interaction reflected in thyroid hormone product labeling and endocrinology practice. Standard guidance is to separate levothyroxine and calcium by at least 4 hours. Tadalafil itself has no bearing on this interaction; the risk exists only because both drugs may be present in the same regimen.

Bisphosphonates

Calcium chelates oral bisphosphonates (alendronate, risedronate) and sharply reduces their bioavailability. Standard bisphosphonate labeling instructs patients to take the bisphosphonate first thing in the morning, with plain water only, and to wait 30 to 60 minutes before any food, beverage, or supplement, including calcium. Tadalafil taken for BPH does not need to be separated from either drug; its timing is independent.

Fluoroquinolones and tetracyclines

Calcium forms insoluble complexes with fluoroquinolone and tetracycline antibiotics, reducing their absorption. Standard practice is to separate calcium from these antibiotics by at least 2 hours before or 6 hours after the antibiotic dose. This is a well-known pharmacology-class interaction; a reader on a short antibiotic course while also taking tadalafil and calcium should apply this spacing regardless of the tadalafil regimen.

Which form of calcium matters

Calcium carbonate (Tums, Caltrate, Os-Cal) needs gastric acid to dissolve and is best absorbed with food. People on long-term proton-pump inhibitors or H2 blockers, sometimes prescribed for reflux in the same patients who take tadalafil, tend to absorb carbonate calcium less reliably in a low-acid stomach environment. Calcium citrate (Citracal) does not require gastric acid and is generally preferred for people on chronic acid suppression, though it costs more per milligram of elemental calcium.

Calcium is also absorbed more efficiently in smaller doses. A single 1,000 mg dose is absorbed less efficiently than the same total split into two doses of 500 mg or less, which is one reason clinicians recommend splitting supplemental calcium across meals.

Evidence-status interaction assessment: calcium and tadalafil

Monitoring for long-term use

Tadalafil at 2.5 to 5 mg is often taken daily for years for BPH or daily ED therapy. Patients on chronic calcium supplementation over the same period benefit from periodic labs: serum calcium (to detect hypercalcemia), intact PTH if calcium is elevated (to rule out primary hyperparathyroidism), and creatinine or eGFR (relevant both to calcium-related kidney stone risk and to tadalafil dosing, since the FDA label reduces the maximum recommended tadalafil dose in significant renal impairment). Frequency of testing should be set by the prescribing clinician based on the individual's supplement dose and risk factors rather than a fixed schedule for everyone.

Practical timing checklist

For someone taking tadalafil daily (2.5 mg or 5 mg) alongside a calcium supplement:

1. Take tadalafil at a consistent time each day; its timing does not need to be coordinated with calcium.
2. Take calcium carbonate with a meal, in doses of 500 mg or less per sitting, for better absorption.
3. If also taking levothyroxine, take levothyroxine on waking with plain water and wait about 4 hours before taking calcium.
4. If also taking a bisphosphonate, take it first thing in the morning with plain water only, and wait 30 to 60 minutes before calcium or food.
5. If also taking a fluoroquinolone or tetracycline antibiotic, separate calcium by at least 2 hours before or 6 hours after the antibiotic dose.
6. If on a long-term PPI or H2 blocker, consider calcium citrate instead of calcium carbonate.
7. Keep total calcium intake (diet plus supplement) near standard adult targets rather than adding a large supplemental dose on top of an already adequate diet; ask a clinician or dietitian to estimate current dietary intake before choosing a supplement dose (see the NIH Office of Dietary Supplements calcium fact sheet for reference intake ranges).

When to contact your prescriber or pharmacist

Reach out if you notice:

• Muscle cramps, confusion, or an irregular heartbeat after starting or increasing calcium (possible signs of hypercalcemia at high intake)
• Blood pressure readings consistently lower than your baseline after starting 20 mg tadalafil combined with high-dose calcium and antihypertensive medication
• Worsening thyroid symptoms (fatigue, weight gain, constipation) if you also take levothyroxine, which can signal that calcium is blunting absorption
• New kidney stones, which should prompt a review of total calcium intake

Voluntary reports of suspected drug-supplement interactions can be submitted to the FDA MedWatch program at fda.gov/safety/medwatch.

What is established, what is plausible, and what is not known

Established: calcium and tadalafil do not share a metabolic pathway, and the FDA label does not list calcium as an interaction. Calcium's interactions with levothyroxine, bisphosphonates, and certain antibiotics are well documented and independent of tadalafil use.

Plausible but unproven: in men who already carry cardiovascular risk factors, the combination of tadalafil's mild vasodilation and calcium's debated cardiovascular signal is a reasonable topic for clinical discussion, even though no study has tested this specific combination directly.

Not established: any specific numeric change in cardiovascular risk, or any interaction affecting tadalafil's effectiveness, from combining it with a calcium supplement. Readers should treat precise risk percentages found elsewhere with caution until a clinician confirms them against the primary literature.

This information does not replace individualized medical advice. Dosing decisions for tadalafil and for calcium supplementation should be made with a prescriber or pharmacist who knows your full medication list, kidney function, and cardiovascular history.